IR NEWS

December 2022

December 20, 2022Information
Received CDP “A-“ in Climate Change and “B” in Water Security
December 6, 2022Financial
Q&A Session Transcript(Summary)

November 2022

November 18, 2022Information
Making Nissui Pharmaceutical as a Wholly-Owned Subsidiary
Expanding the Clinical Testing Business Based on Synergies between Analytical and Measuring Instruments and Culture Media/Reagents
November 8, 2022Financial
1st Half Results & Financial Position for the Fiscal Year Ending March 2023
November 7, 2022Financial
Earnings Report for the six months ended September 30, 2022
November 7, 2022Financial
DATABOOK

August 2022

August 10, 2022Financial
Q&A session Transcript(summary)
August 5, 2022Financial
Earnings Report for the three months ended June 30, 2022
1st Quarter Results ＆ Financial Position for the Fiscal Year Ending March 2023 (FY 2022)
August 5, 2022Financial
DATABOOK

July 2022

July 27, 2022Information
Corporate Governance Report

June 2022

June 29, 2022Information
Corporate Governance Policy (Revised)
June 28, 2022Information
NOTICE OF RESOLUTIONS AT THE 159TH ANNUAL GENERAL MEETING OF SHAREHOLDERS

May 2022

May 26, 2022Information
FY 2020-2022 Medium-Term Management Plan (Update Due to the Upward Adjustment of Performance Targets)
May 24, 2022Financial
Q&A session Transcript(summary)
May 20, 2022Information
NOTICE OF THE 159TH ANNUAL GENERAL MEETING OF SHAREHOLDERS
May 19, 2022Financial
FY2021 Operating Results & Financial Position
May 10, 2022Financial
Earnings Report for the fiscal year ended March 31, 2022
May 10, 2022Timely Disclosure
Notice Regarding Dividends of surplus
May 10, 2022Financial
DATABOOK
May 10, 2022Information
Fact Book 2022

April 2022

April 15, 2022Information
Shimadzu Group Sets New CO₂ Emission Reduction Targets Moving toward net zero CO₂ emissions from overall business activities by 2050

March 2022

March 22, 2022Information
For the Sixth Consecutive Year, Shimadzu was Selected as a Nadeshiko Brand that Actively Empowers Women within the Company
March 9, 2022Information
Selected as a “Health and Productivity Management Brand” for the Second Consecutive Year
Recognized as “White 500” Company with Superior Health Management Practices

February 2022

February 25, 2022Timely Disclosure
Notice of Changes in Executive Members
February 24, 2022Financial
Q&A session Transcript(summary)
February 22, 2022Information
Growth Strategy for Analytical & Measuring Instruments Business
February 15, 2022Financial
3rd Quarter Results & Financial Position for the Fiscal Year Ended March 2022
February 4, 2022Financial
Earnings Report for the nine months ended December 31, 2021
February 4, 2022Financial
DATABOOK

January 2022

January 31, 2022Timely Disclosure
Appointment of New Chairman of the Board and New President & CEO

December 2022

December 6, 2022Financial
Q&A Session Transcript(Summary)

November 2022

November 8, 2022Financial
1st Half Results & Financial Position for the Fiscal Year Ending March 2023
November 7, 2022Financial
Earnings Report for the six months ended September 30, 2022
November 7, 2022Financial
DATABOOK

August 2022

August 10, 2022Financial
Q&A session Transcript(summary)
August 5, 2022Financial
Earnings Report for the three months ended June 30, 2022
1st Quarter Results ＆ Financial Position for the Fiscal Year Ending March 2023 (FY 2022)
August 5, 2022Financial
DATABOOK

May 2022

May 24, 2022Financial
Q&A session Transcript(summary)
May 19, 2022Financial
FY2021 Operating Results & Financial Position
May 10, 2022Financial
Earnings Report for the fiscal year ended March 31, 2022
May 10, 2022Financial
DATABOOK

February 2022

February 24, 2022Financial
Q&A session Transcript(summary)
February 15, 2022Financial
3rd Quarter Results & Financial Position for the Fiscal Year Ended March 2022
February 4, 2022Financial
Earnings Report for the nine months ended December 31, 2021
February 4, 2022Financial
DATABOOK

December 2022

December 20, 2022Information
Received CDP “A-“ in Climate Change and “B” in Water Security

November 2022

November 18, 2022Information
Making Nissui Pharmaceutical as a Wholly-Owned Subsidiary
Expanding the Clinical Testing Business Based on Synergies between Analytical and Measuring Instruments and Culture Media/Reagents

July 2022

July 27, 2022Information
Corporate Governance Report

June 2022

June 29, 2022Information
Corporate Governance Policy (Revised)
June 28, 2022Information
NOTICE OF RESOLUTIONS AT THE 159TH ANNUAL GENERAL MEETING OF SHAREHOLDERS

May 2022

May 26, 2022Information
FY 2020-2022 Medium-Term Management Plan (Update Due to the Upward Adjustment of Performance Targets)
May 20, 2022Information
NOTICE OF THE 159TH ANNUAL GENERAL MEETING OF SHAREHOLDERS
May 10, 2022Information
Fact Book 2022

April 2022

April 15, 2022Information
Shimadzu Group Sets New CO₂ Emission Reduction Targets Moving toward net zero CO₂ emissions from overall business activities by 2050

March 2022

March 22, 2022Information
For the Sixth Consecutive Year, Shimadzu was Selected as a Nadeshiko Brand that Actively Empowers Women within the Company
March 9, 2022Information
Selected as a “Health and Productivity Management Brand” for the Second Consecutive Year
Recognized as “White 500” Company with Superior Health Management Practices

February 2022

February 22, 2022Information
Growth Strategy for Analytical & Measuring Instruments Business

May 2022

May 10, 2022Timely Disclosure
Notice Regarding Dividends of surplus

February 2022

February 25, 2022Timely Disclosure
Notice of Changes in Executive Members

January 2022

January 31, 2022Timely Disclosure
Appointment of New Chairman of the Board and New President & CEO

Related Information

Timely Disclosure

Information Disclosure Policy

Cautionary Statement